Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)1990-472XФедеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации443610.18499/1990-472X-2011-0-43-84-94Review articleCARDIOVASCULAR SYSTEM, INFLAMMATION AND MAGNESIUMRodosskaiaN Kdnv@box.vsi.ruShapovalovaI Ssamalet66@gmail.comVoronezh N.N. Burdenko Medical Academy1512201143849425042020Copyright © 2011, Научно-медицинский вестник Центрального Черноземья2011Pathogenesis of atherosclerosis is associated with the vascular wall inflammation: chronic hyperproduction of proinflammatory cytokines, C-reactive protein, homocysteine. There is a lack of magnesium in the patients with cardiovascular disease body. The replenishment of magnesium deficiency is an important aspect of patients with cardiovascular diseases treatment.сердечно-сосудистая патологияатеросклерозвоспалениемагний1.Klimov A.N. Immunoreactivity and atherosclerosis /A.N. Klimov.- L.: Meditsina, 1986.- 192p.2.Atherogenesis as a reflection of immune inflammation in the vascular wall /V.A. Nagornev, O.A.Yacovleva, S.V.Maltceva //Vestnik RAMN.- 2000.-№ 10.- P.364 - 371.3.Role of mediator mechanisms in the immunopathogenesis of inflammation in cardiovascular disease and osteoporosis /V.V.Tsurko, et al. //Therapeutic Archives.- 2009.-№ 6.- P.92 -96.4.Timomimetick peptides in the treatment of atherosclerosis /V.N.Chlustov, V.N. Kovaleva, M.T.Abidov //Basic Research.- 2007.- №7.- P.57-59.5.Oxidative stress and antioxidants /L.L.Schoonover //Prog. Cardiovasc. Nurs.-2001.- Vol.16, N1.- Р.30-32.6.Endothelium and acute coronary syndrome /J.K.Liao //Clin. Chem.- 1998.- Vol.44, N.- Р.1799-1808.7.Atherosclerosis – an inflammatory disease /R.Ross //N. Engl. J. Med.- 1999.- Vol.340, N.- Р.15-126.8.A tale of two diseases: atherosclerosis and rheumatoid arthritis /V.Pasceri, E.T.Yeh //Circulation.- 1999.- Vol.100, N.- Р.2124-2126.9.Cardiovascular problems in rheumatology /V.I.Mazurov, S.V.Stolov, V.A. Yakusheva, et al. //Research and practical rheumatology.- 2006.- №4.- P.28-34.10.Apolipoprotein (a) - a marker of atherosclerosis activity /V.N.Titov // Therapeutic Archives.- 1993.- №12.- P.79-82.11.Atherosclerosis: basic mechanism oxidation, inflammation, and genetic / J.A.Berliner, M.Navab, A.M.Fogelman et al. //Circulation.- 1995.- Vol.91, N.- Р. 2488-2496.12.Risk factors for cardiovascular disease in patients with rheumatoid arthritis / A.P. Rebrov, N.M. Nikitina //Clinical Medicine.- 2008.- №2.- P.56-59.13.State of the vascular wall during latent infection in individuals with varying degrees of atherosclerosis /A.P. Shavrin, Y.B.Khovaeva, B.V.Golovskoy, A.I. Aminova /Clinical Medicine.- 2009.- № 1. - P.36-39.14.Holesterol-including circulating immune complexes - a component of blood serum in patients with coronary heart disease /V.V.Tertov, V.G.Kacharova, H.S.Sadayan / Cardiology.- 1989.- № 8.- P.35-38.15.Immunoinflammatory activation as a conceptual model for the formation and progression of heart failure /V.A.Vizir, A.A.Berezin /Therapeutic Archives.- 2004.- № 4.- P.77-80.16.Plasma levels of TNF-α and interleukin-6 in patients with acute myocardial infarction: relation to the presence of myocardial stunning /W.Kosmala, A.Spring //Eur. Heart J.- 2000.- N21(suppl.).- P.665.17.Suppressant effect of recombinant immunomodulator roncoleukine the level of proinflammatory cytokines, autoantibodies to cardiolipin in the blood and heart failure /A.T.Teplyakov, L.A.Bolotskaya, T.A.Stepacheva et al. //Cardiology.- 2008.- № 8.- P.34-40.18.Comparative evaluation of anti-inflammatory effect of atorvastatin in coronary heart disease and rheumatoid arthritis /V.S.Tutunov, T.V.Popkova, D.S.Novikova et al. //Cardiology.- 2008.- № 9.- P.4-8.19.Dietary Magnesium and C-reactive Protein Levels /Dana E. King, Arch G. Mainous, Mark E. Geesey, Robert F. Woolson //Journal of the American College of Nutrition.- 2005.- Vol.24, N3.- Р.166-171.20.Serum magnesium and C-reactive protein levels /M. Rodriguez-Moran, F. Guerrero-Romero //Arch. Dis. Child.- 2008.- Vol.93, N.- P.676-680.21.Metabolic syndrome as a harbinger of diabetes type 2 and cardiovascular diseases /M.V.Shestakova, S.A.Butrova, O.U.Sukhareva //Therapeutic Archives.- 2007.- Vol.79, N10.- P.5-8.22.A novel component of the metabolic syndrome: The oxidative stress. /E.Hopps, D.Noto, G.Caimi, M.R.Averna //Nutrition, Metabolism and Cardiovascular Diseases.- 2010.- Vol.20, N1.- P.72-77.23.Inflammation of adipose tissue and atherosclerosis /B. Schwartz /Cardiology.- 2009.- № 12.- P.80-86.24.Dietary factors that promote or retard inflammation /Arpita Basu, Sridevi Devaraj, Ishwarlal Jialal //Arteriosclerosis, Thrombosis, and Vascular Biology.- 2006.- Vol.26,N.- P.995-1001.25.Dietary magnesium and fiber intares and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort /Simona Bo, Marilena Durazzo, Sabrina Guidi et al. //American Journal of Clinical Nutrition.- 2006.- Vol.84, N5.- P.1062-1069.26.Magnesium intake and plasma concentration of markers of systemic inflammation and endothelial dysfunction in women /Yiqing Song, Tricia Y Li, Rob M van Dam et al. //American Journal of Clinical Nutrition.- 2007.- Vol. 8,N4.- P.1068-1074.27.Superoxide-mediated activation of cardiac fibroblasts by serum factors in hypomagnesemia /C.Kumaran, K.Shivakumar //Free Radical biology and Medicine.- 2001.- Vol.31,N7.- P.882-886.28.Rude R.K. Magnesium. / M.E. Shils, M. Shike, A.C. Ross et al. //Modern Nutrition in Health and Disease.- Baltimore: Lippincott Williams & Wilkins.-2006.- 10th ed.- P.223-247.29.Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women /Sara A. Chacko, Yiqing Song, Lauren Nathan et al. //Diabetes Care.- 2010.-Vol.3, N2.- P.304-310.30.High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro /Jeanette A.M Maier, Daniela Bernardini, Yves Rayssiguier and Andrzej Mazur //Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease.- 2004.- Vol.1689, N1.- P.6-12.31.Effects of magnesium on the production of extracellular matrix metalloproteinases in cultured rat vascular smooth muscle cells /Yue H, Lee JD, Shimizu H et al. //Atherosclerosis.- 2003.- Vol.166, N2.- P.271-277.32.High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro /Jeanette A.M Maier, Corinne Malpuech-Brugère, Wioletta Zimowska et al. //Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease.- 2004.- Vol.1689, N1.- P.13-21.33.Contribution of neurohumoral dysfunction and increased body weight for hypertension /S.S. Bubnova //Therapeutic Archives.- 2009.- № 5.- P.71-74.34.Dietary and serum magnesium levels in patients with acute myocardial infarction, coronary artery disease, and non-cardiac diagnoses /R.B.Singh, S.S.Rastogi, S.Ghosh, M.A.Niaz //J. Am. Coll. Nutr.- 1994.- Vol.13,N.- P.139-143.35.Magnesium, Antioxidants and Myocardial Infarction /Mildred S. Seelig //Journal of the American College of Nutrition.- 1994.- Vol.13, N2.- P.116-117.36.Magnesium deficiency-induced cardiomyopathy; protestiom by vitamin E /A.M.Freedman, A.H.Atrakshi, M.M.Cassidy, W.B.Weglicki //Biochem. Biophys. Res. Commun.- 1990.- Vol.70, N.- P.1102-1106.37.Magnesium-deficient myocardium demonstrates an increased susceptibility to an in vivo oxidative stress /A.M.Freedman, M.M.Cassidy, W.B.Weglicki //Magnesium Res.- 1991.- Vol.4, N.- P.185-189.38.The action of extracellular cations on the release of the sympathetic transmitter from peripheral nerves /D.J.Boullin //J. Physiol.- 1987.- Vol.189, N.- P.85-89.39.Magnesium, Antioxidants and Myocardial Infarction /Mildred S. Seelig //Journal of the American College of Nutrition.- 1994.- Vol.13, N2.- P.116-117.40.Nitric oxide and atherosclerosis. Nitric oxide, vascular endothelial dysfunction and the pathogenesis of atherosclerosis /H.M.Markov //Cardiology.- 2009.- №11.- P.64-74.41.Hyperhomocysteinemia as a risk factor for occlusive vascular disease /S.S.Kang SS, P.W.K.Wong, M.R.Malinov //Annu. Rev. Nutr.- 1992.- Vol.12, N.-P.272-298.42.Shevchenko O.P. Homocysteine /O.P.Shevchenko, G.A.Olefirenko, N.V. Chervyakova.- M.: Reafarm, 2002.- 48p.43.Higher plasma homocysteine and increased susceptibility to adverse effect of low folate in early familial coronary artery disease /P.N.Hopkins, J.Wu //Atherosclerosis.- 1995.- Vol.15, N.- P.1314-1320.44.Rage mediates a novel proinflammatory axis: a central cell surface receptor for S100/ calgranulin polypeptides. /M.A.Hoffmann, S. Drury, C. Fu et al. //Cell.- 1999.- Vol.97, N.- P.889-901.45.Plasma homocysteine predicts mortality independently of traditional risk factors and C-Reactive protein in patients with angiographically defined coronary artery disease /J.L.Anderson, J.B.Muhlestein, B.D.Horne BD et al. //Circulation.- 2000.- Vol.102, N.- P.1227-1232.46.Effects of folic acid and magnesium on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells / H.Guo, Jd.Lee, H.Uzui H. et al. //Circ. J.- 2006.- Vol.70, N1.- P.141-146.47.Extracellular magnesium regulates effects of vitamin B6, B12 and folate on homocysteinemia-induced depletion of intracellular free magnesium ions in canine cerebral vascular smooth muscle cells: possible relationship to [Ca2+]i, atherogenesis and stroke /W. Li, T.Zheng, J.Wang et al. //Neurosci. Lett.- 1999.- Vol. 274(2), N22.- P.83-86.48.Increased need for magnesium with the use of combined oestrogen and calcium for osreoporosis treatment /Mildred S. Seelig //Magnesium Research.- 1990.- Vol.3, N3.- P.197-215.49.Gromova O.A. Magnesium and pyridoxine: basic knowledge /O.A. Gromova.- M.: 2006.- 176 p.50.Akarachkova E.S. Magnesium and its role in human life and health /E.S. Akarachkova /Reference outpatient physician.- 2009.- № 5.- P.6-10.